Our research found the levels of anti-S1 IgG, anti-S1A IgG, and anti-RBD IgG in COVID-19 patients with severe symptoms were significantly higher than those in patients having mild or moderate symptoms. The gene discussed is PSMD1; the disease is COVID-19.